Advertisement
Hyperfine Inc. (HYPR)
NASDAQ: HYPR
· Real-Time Price · USD
0.73
-0.01 (-2.00%)
Apr 29, 2025, 10:22 AM - Market open
Company Description
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products.
It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services.
The company was incorporated in 2014 and is based in Guilford, Connecticut.
Hyperfine Inc.
| Country | United States |
| IPO Date | Jan 28, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 111 |
| CEO | Maria Sainz |
Advertisement
Contact Details
Address: 351 New Whitfield Street Guilford, Connecticut United States | |
| Website | https://hyperfine.io |
Stock Details
| Ticker Symbol | HYPR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001833769 |
| CUSIP Number | 44916K106 |
| ISIN Number | US44916K1060 |
| Employer ID | 00-0000000 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Maria Sainz | Chief Executive Officer, President & Director |
| Brett Hale | Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer & Corporate Secretary |
| Dr. Thomas Teisseyre Ph.D. | Chief Operating Officer |
| Chip Truwit FACR, M.D. | Senior Vice President of Office Strategy and Partnerships |
| Dr. Jonathan M. Rothberg Ph.D. | Founder & Vice Chairman |
| Edmond Knopp M.D. | Chief Medical Officer |
| R. Scott Huennekens CPA, M.B.A. | Executive Chairman |
| Rafael Donnay | Senior Vice President of Hospital Strategy & Health Economics |
| Rafael O'Halloran | Vice President of Technology |
| Rob Fasciano | Chief Regulatory & Quality Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 07, 2025 | ARS | Filing |
| Apr 07, 2025 | DEFA14A | Filing |
| Apr 07, 2025 | DEF 14A | Filing |
| Mar 17, 2025 | S-8 | Filing |
| Mar 17, 2025 | 10-K | Annual Report |
| Mar 17, 2025 | 8-K | Current Report |
| Feb 20, 2025 | 4/A | [Amend] Filing |
| Feb 18, 2025 | 4 | Filing |
| Feb 11, 2025 | 8-K | Current Report |
| Feb 11, 2025 | 424B5 | Filing |